TICKERNOMICS Sign up
Last Update: 2024-12-27 15:30:11
Avinger Inc ( AVGR ) https://avinger.com
1.28USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-56.01%
AVGR
SPY
32.66%
-99.13%
AVGR
SPY
108.59%
-99.63%
AVGR
SPY
302.52%
AVGR
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
1.43
-3.05
4.84
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.08
0.20
0.37
-524.21
0.00
0.18
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-222.36
25.82
-248.17
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.9936
-105.18
-4604.73
1.27
Other Earnings and Cash Flow Stats:
Avinger Inc ( AVGR ) Net Income TTM ($MM) is -18.61
Avinger Inc ( AVGR ) Operating Income TTM ($MM) is -17.50
Avinger Inc ( AVGR ) Owners' Earnings Annual ($MM) is -14.56
Avinger Inc ( AVGR ) Current Price to Owners' Earnings ratio is -0.13
Avinger Inc ( AVGR ) EBITDA TTM ($MM) is -17.76
Avinger Inc ( AVGR ) EBITDA Margin is -248.17%
Capital Allocation:
Avinger Inc ( AVGR ) has paid 0.00 dividends per share and bought back -1.526 million shares in the past 12 months
Avinger Inc ( AVGR ) has increased its debt by 0.043 million USD in the last 12 months
Capital Structure:
Avinger Inc ( AVGR ) Interest-bearing Debt ($MM) as of last quarter is 1
Avinger Inc ( AVGR ) Annual Working Capital Investments ($MM) are -6
Avinger Inc ( AVGR ) Book Value ($MM) as of last quarter is 3
Avinger Inc ( AVGR ) Debt/Capital as of last quarter is 36%
Other Balance Sheet Stats:
Avinger Inc ( AVGR ) has 5 million in cash on hand as of last quarter
Avinger Inc ( AVGR ) has 9 million of liabilities due within 12 months, and long term debt 4 as of last quarter
Avinger Inc ( AVGR ) has 2 common shares outstanding as of last quarter
Avinger Inc ( AVGR ) has 0 million USD of preferred stock value
Academic Scores:
Avinger Inc ( AVGR ) Altman Z-Score is -47.94 as of last quarter
Avinger Inc ( AVGR ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
Avinger Inc ( AVGR ) largest shareholder is Householder Group Estate & Retirement Special owning 1 shares at 0.00 ($MM) value
Nabeel Paul Subainati(an insider) Sold 14 shares of Avinger Inc ( AVGR ) for the amount of $170.10 on 2023-03-23
13.60% of Avinger Inc ( AVGR ) is held by insiders, and 2.84% is held by institutions
Avinger Inc ( AVGR ) went public on 2015-01-30
Other Avinger Inc ( AVGR ) financial metrics:
FCF:-14.56
Unlevered Free Cash Flow:-16.21
EPS:-6.67
Operating Margin:-222.36
Gross Profit Margin:25.82
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-382.55
Beta:1.27
Buffet's Owners Earnings:-14.56
Price to Owner's Earnings:-0.13
About Avinger Inc ( AVGR ) :
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.